In the past, PR was considered an indicator of functional ER activity because PR is the product of ER target genes, and the synthesis of PR protein is regulated by ER [10], but recent evidence shows that the regulatory processes of PR function and target genes are separated from ER, which is an independent motor of cell proliferation in breast cancer [11]. This evidence concerns the gene ESR1 and breast carcinoma.